Dartmouth Health is offering treatments and preventive therapies for those who are eligible. These treatments and therapies are currently in extremely limited supply.
Treatments are used for those who have already tested positive for COVID-19 and are at high risk of getting severe disease if they are infected with COVID-19.
Dartmouth Health is offering several new treatments for COVID-19 on an outpatient basis. These treatments remain active against all known COVID-19 variants.
Please contact your primary care provider to determine your best treatment option for COVID-19.
Preventive therapies are used to prevent COVID-19 infections for those who are at high risk of getting severe disease if they are infected with COVID-19.
Dartmouth Health will be offering AstraZeneca’s Evusheld™ (tixagevimab and cilgavimab), a monoclonal antibody designed to provide additional immunity and prevent COVID-19 in individuals 12 years of age or older who are moderately to severely immunocompromised. Evusheld may also be used in individuals who are not able to receive the available COVID-19 vaccines due to a history of severe adverse reaction.